Table 2.
Psychopathology and Functioning Scores by Serostatus at Baseline
| Baseline Measure | NMDAR Ab Negative, n = 373 | NMDAR Ab Positive, n = 15 | Ba | p Value, NMDAR Ab Negative vs. Positive |
|---|---|---|---|---|
| PANSS Total | 78.78 ± 19.00 | 75.80 ± 19.10 | 3.27 | .513 |
| PANSS Positive | 20.12 ± 5.55 | 20.13 ± 6.38 | 0.096 | .949 |
| PANSS Negative | 19.89 ± 7.10 | 17.80 ± 6.95 | 1.92 | .302 |
| PANSS General | 38.76 ± 9.99 | 37.87 ± 9.86 | 1.26 | .631 |
| CDSS | 13.31 ± 4.48 | 13.07 ± 4.37 | 0.362 | .759 |
| CGI | 5.53 ± 0.92 | 5.53 ± 1.19 | −0.001 | .998 |
Continuous variables are presented as mean ± SD.
Ab, antibody; CDSS, Calgary Depression Scale for Schizophrenia; CGI, Clinical Global Impressions; NMDAR, NMDA receptor; PANSS, Positive and Negative Syndrome Scale.
a
Regression coefficient from multiple regression procedure.